260 related articles for article (PubMed ID: 35064546)
1. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
[TBL] [Abstract][Full Text] [Related]
2. A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.
Zhang T; Zhang S; Jin C; Lin Z; Deng T; Xie X; Deng L; Li X; Ma J; Ding X; Liu Y; Shan Y; Yu Z; Wang Y; Chen G; Li J
Front Cell Infect Microbiol; 2021; 11():751795. PubMed ID: 34888258
[TBL] [Abstract][Full Text] [Related]
3. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
7. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
8. Association of gut microbiome and primary liver cancer: A two-sample Mendelian randomization and case-control study.
Ma J; Li J; Jin C; Yang J; Zheng C; Chen K; Xie Y; Yang Y; Bo Z; Wang J; Su Q; Wang J; Chen G; Wang Y
Liver Int; 2023 Jan; 43(1):221-233. PubMed ID: 36300678
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
10.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
11. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Cho EJ; Kim B; Yu SJ; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Yoon JH; Park T
Br J Cancer; 2024 Apr; 130(6):970-975. PubMed ID: 38278977
[TBL] [Abstract][Full Text] [Related]
12. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
[TBL] [Abstract][Full Text] [Related]
13. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma.
Yang J; He Q; Lu F; Chen K; Ni Z; Wang H; Zhou C; Zhang Y; Chen B; Bo Z; Li J; Yu H; Wang Y; Chen G
Gut Microbes; 2023; 15(1):2201159. PubMed ID: 37089022
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma.
Zheng C; Lu F; Chen B; Yang J; Yu H; Wang D; Xie H; Chen K; Xie Y; Li J; Bo Z; Wang Y; Chen G; Deng T
Cancer Sci; 2023 Dec; 114(12):4717-4731. PubMed ID: 37778742
[TBL] [Abstract][Full Text] [Related]
16. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
[TBL] [Abstract][Full Text] [Related]
17. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients.
Chung MW; Kim MJ; Won EJ; Lee YJ; Yun YW; Cho SB; Joo YE; Hwang JE; Bae WK; Chung IJ; Shin MG; Shin JH
World J Gastroenterol; 2021 Nov; 27(42):7340-7349. PubMed ID: 34876793
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.
Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W
Front Med (Lausanne); 2022; 9():836369. PubMed ID: 35372388
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
Li Z; Zhang Y; Hong W; Wang B; Chen Y; Yang P; Zhou J; Fan J; Zeng Z; Du S
Gut Microbes; 2022; 14(1):2119055. PubMed ID: 36093568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
